Advanced Prostate – Call For Grant (1) - SUO
Bayer funds educational initiatives advancing clinical knowledge and care in advanced prostate cancer, focusing on recent research, evidence gaps, and survivorship using innovative formats.
Funder: Bayer
Due Dates: Rolling (monthly review; submit anytime)
Funding Amounts: No fixed limit; budget must be detailed and justified in proposal.
Summary: Supports educational initiatives advancing care and clinical knowledge in advanced prostate cancer, focusing on recent research, clinical evidence gaps, and survivorship.
Key Information: Allow at least 45 days for a funding decision after submission.
Description
This grant opportunity supports educational projects that address key knowledge gaps and recent advances in advanced prostate cancer, including non-metastatic castrate resistant (nmCRPC), metastatic castrate resistant (mCRPC), and metastatic hormone-sensitive prostate cancer (mHSPC). The program aims to foster improved clinical decision-making and survivorship care by supporting initiatives that integrate new treatment approaches, novel clinical trial designs (including AI and external comparators), and pragmatic evaluation of cognitive, functional, and patient-reported outcomes. Preferred educational formats include enduring materials, downloadable slides, podcasts, live virtual sessions, and social media outreach.
